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ABSTRACT
This is the protocol for a review and there is no abstract. The objectives are as follows:
Primary objective: To determine the effectiveness of organisation-wide interventions to implement person-centred care for people with
dementia, in relation to reduction of behavioural symptoms such as agitation and depression, improvement in quality of life and
functional capabilities, alterations in the use of restraint (physical and/or chemical) and reduction in adverse events.
Secondary objective: To identify the variety, quality, and feasibility of person-centred care approaches for people with dementia, with
specific reference to organisational factors which promote and constrain the implementation of person-centred care.

BACKGROUND

Description of the condition
In developed countries, dementia is one of the leading causes of
disability in people aged over 65 years. It occurs in people of all
cultures and is becoming increasingly common in countries whose
populations are ageing. Worldwide there are over 7.7 million new
cases of dementia each year. Approximately 60% of this disease
burden and the most rapid growth in prevalence in the next decade
(77% to 146%) will fall on low- and middle-income countries
which have the least capacity to cope (World Health Organisation
2015). As population ageing continues to accelerate, the number
of people with dementia is expected to nearly double every 20
years, growing to 65.7 million worldwide by 2030 (Alzheimer’s

Association 2013). Despite wide variations in the proportions of
formal and informal care arrangements for people with dementia
in different regions of the world, there are similar social and economic costs (World Health Organisation 2014).
Dementia is classified in the fifth edition of the Diagnostic
and Statistical Manual of Mental Disorders (DSM-5) (American
Psychiatric Association 2013) as a major neurocognitive disorder,
encompassing a range of degenerative conditions characterised by
progressive decline in cognition and impairment in function. It
is typically irreversible; currently there is no approved treatment
available to prevent progression or to cure the disease. The most
common type of dementia is Alzheimer’s disease (approximately
50% to 75%), which occurs usually after 65 years of age and is characterised by the accumulation of abnormal proteins in the brain
in the form of amyloid plaques and neuritic tangles (Alzheimer’s
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Disease International 2013). The next most common type is vascular dementia (20% to 40%), which results from decreased blood
flow and hence impaired supply of oxygen and nutrients to the
brain. Brain damage from major vascular events usually progresses
in a step-wise fashion of deterioration and stabilisation, but disease of the small intracerebral vessels typically presents as dementia with a more insidious course. Death often occurs following
a major stroke (Alzheimer’s Association 2014a). Dementia with
Lewy bodies (DLB) and dementia in Parkinson’s disease (PDD)
are closely related conditions in which degeneration of nerve cells
is again thought to be due to abnormal protein deposits, in this
case in the form of intracellular Lewy bodies (Alzheimer’s Australia
2013). Frontotemporal dementia (FTD) often commences between 40 and 65 years of age, occurs in 5% to 10% of cases of dementia, and is associated with a variety of pathologies (Alzheimer’s
Australia 2013). With older age, the cause of dementia is more
likely to be mixed, with combinations of Alzheimer’s and vascular
pathology being most common, although other mixed pathologies
also occur. Early-onset dementia describes any form of dementia
occurring in people under 65 years of age, with the main subtypes being alcohol-related dementia (22%), Alzheimer’s disease
(16%), frontotemporal dementia (13%) and vascular dementia
(10%) (Draper 2011). Other forms of dementia occur with Korsakoff Syndrome, Huntington’s disease, traumatic brain injury
and HIV/AIDS (Alzheimer’s Association 2014b).
There are often subtle changes in a person’s behaviour and function before the formal diagnostic criteria for dementia are met.
Symptoms typically include impairment of language, memory,
perception, personality and cognitive skills. As the disease progresses there will be a decline in intellect, judgement, social skills,
ability to manage daily functions and socially-tolerated emotional
reactions. Some of the psychological responses in people with dementia include depression, psychosis, aggression and wandering
from home (Alzheimer’s Association 2013). Criteria for diagnosing dementia are outlined in the DSM-5 (American Psychiatric
Association 2013). Cognitive changes must be assessed relative to
the person’s background cognitive ability, using culturally-sensitive and validated measures of physical and psychosocial function.
This is especially important for people outside societal ‘norms’,
including high-functioning individuals (who may not fit usual diagnostic criteria for dementia), those with special needs such as
people with cultures and languages different from the mainstream
society, and those with younger onset dementia and intellectual
disability. Cognitive assessments need to be supplemented by a
detailed longitudinal account, provided by an informant, of the
person’s health and social history with a focus on functional impairment. When appropriate measurement and interviewing styles
are utilised in a quiet, safe and relaxed environment, people with
dementia can provide reliable self-reports about their daily living
activities and past life experiences. Utilising reminiscence during
the interview assists in attending to cues and explicit references
to symptoms conveyed by the person (Clare 2005; Clark 2008;

Kolanowski 2007). A physical examination and clinical investigations should also be conducted to rule out reversible causes.

Description of the intervention
Person-centred approaches to dementia care are based on the notion that the unique identity, personality and subjective reality of
person living with dementia remain, despite the presence of a disease process (Kitwood 2007). Carl Rogers, one of the 20th century’s most influential humanistic psychologists, founded the person-centred approach to care. “Rogers proposed that a person-centred approach, based on acceptance, caring, empathy, sensitivity,
and active listening, promotes optimal human growth” (Brownie
2013, p.2). As a response to the increasing disenfranchisement
of people living with dementia in long-term care homes, social
psychologist Tom Kitwood (Kitwood 2007) developed a model
of person-centred care. His model challenged the notion that dementia leads to a loss of the person and, thus, to faulty interpretations of symptoms associated with dementia. Person-centred care
operates from a perspective that many of these symptoms, such as
agitation and aggression, are a result of the person’s interactions
within the psychosocial world. The ’social-psychological theory of
personhood in dementia’ (Kitwood 2007) is the basis for the person-centred care model, proposing that people exist in a social, relational context, and that positive and enriching interpersonal relationships can prevent the disabling effects of dementia and promote a sense of well-being (Brooker 2003; Davis 2004; Dewing
2008). The theory recognises the persistence of ‘personhood’ despite other losses that are occurring in dementia; supported by evidence that people with dementia retain a sense of identity (Rankin
2005) and the ability to communicate their wants, needs and desires (Mayhew 2001). Person-centred care, therefore, aims to support the person’s identity by meeting their needs for love, attachment, comfort, occupation and inclusion. When these psychosocial needs are met, the person will have a sense of self-worth and
feel valued, and there will be fewer expressions of ill-being, which
are generally expressed in various forms of agitated and/or apathetic behaviour (Brooker 2007a; Slater 2006).
Person-centred care focuses its attention on maintaining and nurturing personhood. Person-centred care achieves its goal by adherence to a set of guiding principles:
1. Create and strengthen a positive relationship with the
person through warm and accepting human contact.
2. Communicate respectfully, value and honour the person.
3. Treat the person as a sentient and unique human being, by
valuing their innate nature and assisting them to retain their
remaining strengths.
4. See the person’s world from their perspective in all
interactions with them.
5. Help the person to feel socially confident and to maintain
emotional attachment to others.
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6. Assist the person to have choice and to make decisions
about their own life.
7. Make use of the person’s positive memories to help improve
their self-esteem and maintain their identity.
8. Treat the person’s behaviour as a way of communicating
their feelings and needs and respond to the behaviour with
empathy (Brooker 2007a).
Implementing person-centred care means promoting a system of
social relationships that have the potential to mitigate the disabling effects of dementia through adherence to these principles
in all interactions with the person (Davis 2004). The model relies on carers ‘knowing the person’ with dementia, understanding their unique life story, values and belief systems, preferences
and idiosyncratic needs. This personal knowledge enables carers
to engage with the person with dementia and form meaningful
relationships with them. As a result the person with dementia is
more secure in their environment, feels acknowledged as a person
and is, therefore, less likely to become distressed or agitated.
Achieving these desirable outcomes is not only a matter of individuals learning the skills of person-centred care. It requires organisational leadership at all levels in order to address the structural barriers that prevent the adoption and maintenance of system-wide person-centred service, whether the system is a hospital ward, a day centre or a residential care home. The model is
best implemented when the entire system is framed by policies to
guide implementation across the organisation. All systems must
operate to support personhood as the primary aim. This change in
ethos requires organisational commitment to person-centred care
and the education, training and supervision of all people involved
in supporting the person’s activities of daily living (Alzheimer’s
Disease International 2014). A shift in the system’s loci of authority, control and power may, therefore, be required to support a
person-centred service.
A number of different aspects of the organisation have been
targeted in implementing person-centred care, including: organisational culture (Caspar 2009; Kane 2007); management
systems (Miller 2010; Tellis-Nayak 2007); quality monitoring
and improvement systems (Brooker 2007a); staff education and
training (Chenoweth 2009; Fossey 2006; Stein-Parbury 2012);
care planning prioritisation (Ashburner 2004); practice guidelines for specific issues such as resistance during personal care
(Cohen-Mansfield 1999); care monitoring and staff support models such as Dementia Care Mapping (Brooker 2005; Fulton 2006);
enriched activity programs (Brooker 2007b); and nursing guidelines (McCormack 2006).

How the intervention might work
As described above, person-centred care challenges the conventional constructions of dementia that can result in depersonalisation, treating the person as if they are no longer ‘there’ and focusing on their deficits (Davis 2004). A person-centred approach en-

ables carers to interpret the behaviours of a person with dementia,
not as a function of their illness, but rather as a response to what
is happening to and occurring around them in their psychosocial
milieu. Carers come to understand that it is how the person with
dementia is being regarded and treated that can trigger behaviours,
like aggression and resistance, during care events.
The review will consider person-centred interventions within the
organisation which aim to support one or more of the ’VIPS’
constructs (Røsvik 2013):
• Valuing: asserting the absolute value of the person’s
humanity.
• Individual care: recognising and responding to the person’s
uniqueness.
• Perspective: interpreting the person’s actions/behaviour
from their perspective.
• Social psychology: prioritising the person’s well-being.
The VIPS constructs are relevant because they operate to support
person-centred care across the entire organisation, by enabling the
organisational structures that promote implementation.

Why it is important to do this review
Internaionally, people with dementia will eventually need some
level of formal health and social care assistance, to complement
and/or replace the care and support provided by their families
(Alzheimer’s Disease International 2014). Formal health and social
care services operate in complex systems, which are bounded by the
political, policy, economic, social and cultural frameworks unique
to each culture and geographical region. While there is no unitary
system and level of support that is suitable for all people with
dementia, it is incumbent on governments and societies to ensure
that, as far as possible, health and social care services are available
to people with dementia and their families, and that services are
dementia- inclusive (World Health Organisation 2014).
Family care for people with dementia is still common practice in
most middle- and lower-income countries. In middle- and higherincome countries, the range of services available for the person and
their family can include family support and respite, home help,
personal care, palliative care, residential and assisted living support, long-term care assistance and nursing care, and hospital care.
Each type of service has its own philosophical and policy framework, financial arrangement and requirements in service provision
(Alzheimer’s Association 2013). Despite these differences, formal
service providers have a mandate to provide quality, evidencebased care and support to people with dementia and their families
(American Psychiatric Association 2013). When services are dementia-inclusive, that is, they focus effort on adapting services to
the needs of the individual, they can improve life for the person
and their carer/s (Brownie 2013; León-Salas 2013; NICE 2010).
A small number of dementia care service models have proved effective (Beerens 2013).
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One care model which has international appeal and evidence for
its effectiveness and efficacy is the person-centred approach advocated by Tom Kitwood (Kitwood 1997). While there have been
some criticisms of the model within the context of care relationships (Adams 2005; Nolan 2006b; Price 2006), the level of interest in person-centred care is growing. It has been adapted for use
in acute, community and long-term care contexts in different cultures and societies (Aged Care Branch 2011; Brownie 2013; Wylie
2002). Person-centred care has been used as a general approach
to improve specific aspects of care and treatment for people with
dementia (Brooker 2007a; Fossey 2006; Sloane 2004), to improve
their well-being (Chenoweth 2009; van de Ven 2013) and in helping to reduce various forms of agitation (Cohen-Mansfield 2012).
Different approaches/techniques to implementing person-centred
care have also proved helpful (Beavis 2002; Brownie 2013).
In many countries, including Australia, the United States, parts
of South America and the Caribbean, Canada, the United Kingdom (UK), the Netherlands, Hong Kong, South Korea, Japan
and across Scandinavia, quality dementia care is a national health
and social priority. The governments of these nations are actively
promoting person-centred dementia and aged care (Alzheimer’s
Association 2013). Given the investments that governments and
service providers are making in developing dementia-inclusive services and communities, it is timely to undertake a rigorous review
of the different person-centred models and care approaches that
are operating across the world. It will be important to advise governments, the health and aged care industries and consumers on
the outcomes of these different person-centred models and care
approaches for people with dementia, their families and service
providers.

OBJECTIVES
Primary objective: To determine the effectiveness of organisationwide interventions to implement person-centred care for people
with dementia, in relation to reduction of behavioural symptoms
such as agitation and depression, improvement in quality of life
and functional capabilities, alterations in the use of restraint (physical and/or chemical) and reduction in adverse events.
Secondary objective: To identify the variety, quality, and feasibility of person-centred care approaches for people with dementia,
with specific reference to organisational factors which promote
and constrain the implementation of person-centred care.

Types of studies
We will include all published and unpublished randomised controlled trials (RCTs), including cluster-randomised trials (CRTs),
recognising that this limits the review by excluding findings from
other designs using qualitative methods. Trials will be included
even if the method of sequence generation is sub-optimal (’quasirandomised’) or unclear, however the inadequacies of the allocation method will be considered a source of selection bias.
Types of participants
Eligible participants will have been diagnosed with dementia according to the appropriate editions of the Diagnostic and Statistical Manual of Mental Disorders (DSM) (American Psychiatric
Association 2013) and the International Classification of Diseases
(ICD) (World Health Organisation 2015). If diagnostic information on participants is not described in potentially-relevant studies, study authors will be asked for additional diagnostic information. Participants will be receiving formal dementia care from an
organisation which may be an individual care home, a chain of
care homes, a hospital or a care agency providing formal care in
these organisations.
Types of interventions
We will include interventions which are explicitly intended to promote the implementation of person-centred care at the organisational level, according to the VIPS constructs (Røsvik 2013; see
How the intervention might work). Interventions may target one
or more of: organisational culture; management systems; quality
monitoring and improvement systems; staff education and training; and care planning prioritisation. They may also include nursing guidelines or practice guidelines for specific issues such as resistance during personal care, or specific techniques which aim to
facilitate person-centred care, including care monitoring and staff
support models such as Dementia Care Mapping (Brooker 2011).
We will not include interventions with an individual focus, such as
personalised activity programmes. The control interventions may
either be ’care as usual’ or ‘standard care’. Studies that compare different approaches to implementing person-centred care will also
be considered.
Types of outcome measures

Primary outcomes

METHODS

Criteria for considering studies for this review

• Frequency and severity of behavioural symptoms measured
with either multi-faceted scales such as the Neuropsychiatric
Inventory (Cummings 1994), scales specific to agitation such as
the Cohen-Mansfield Agitation Inventory (Cohen-Mansfield
1999), or mood scales such as the Cornell Scale of Depression in
Dementia (Alexopoulos 1988).
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• Quality of life, as measured by validated dementia quality
of life instruments.

that will be used for the retrieval of reports of trials from MEDLINE (via the Ovid SP platform) can be seen in Appendix 1.

Secondary outcomes

Searching other resources

• Function in activities of daily living.
• Use of physical/mechanical restraint.
• Use of chemical restraint including psychotropics,
antihistamines, and sedatives.
• Adverse events such as delirium, falls and related injuries,
and pressure ulcers.

We will also:
• handsearch reference lists of all included studies, relevant
systematic reviews and other relevant publications;
• contact authors of relevant studies or reviews to clarify
reported published information and seek unpublished data;
• conduct cited reference searches for all included studies, in
ISI Web of Knowledge.

Search methods for identification of studies
Relevant studies will be identified by searching various databases.
Electronic searches
We will search ALOIS (www.medicine.ox.ac.uk/alois) - the
Cochrane Dementia and Cognitive Improvement Group’s (CDCIG) specialised register.
ALOIS is maintained by the Trials Search Co-ordinator for the
CDCIG, and contains studies that fall within the areas of dementia prevention, dementia treatment and management, and cognitive enhancement in healthy elderly populations. The studies are
identified through:
1. Monthly searches of a number of major healthcare
databases: MEDLINE, EMBASE, CINAHL, PsycINFO and
Lilacs;
2. Monthly searches of a number of trial registers: ISRCTN;
UMIN (Japan’s Trial Register); the WHO portal (which covers
ClinicalTrials.gov; ISRCTN; the Chinese Clinical Trials Register;
the German Clinical Trials Register; the Iranian Registry of
Clinical Trials and the Netherlands National Trials Register, plus
others);
3. Quarterly search of The Cochrane Library’s Central Register
of Controlled Trials (CENTRAL);
4. Six-monthly searches of a number of grey literature sources:
ISI Web of Knowledge Conference Proceedings; Index to
Theses; Australasian Digital Theses.
To view a list of all sources searched for ALOIS see About ALOIS
on the ALOIS website (www.medicine.ox.ac.uk/alois).
Details of the search strategies run in healthcare bibliographic
databases, used for the retrieval of reports of dementia, cognitive
improvement and cognitive enhancement trials, can be viewed in
the ‘Methods used in reviews’ section within the editorial information about the Cochrane Dementia and Cognitive Improvement
Group on The Cochrane Library.
We will run additional searches in MEDLINE, EMBASE,
PsycINFO, CINAHL, ClinicalTrials.gov and the WHO Portal/
ICTRP to ensure that the searches for each suite of reviews is as
comprehensive and as up-to-date as possible. The search strategy

Data collection and analysis
The first review author (LC) will execute the search strategy as
described, supported by the second and third authors (JS-P, SL).
Any studies on PCC undertaken by the review authors that are
deemed eligible for inclusion in the review will be assessed for
study selection, extract data and ’Risk of bias’ by an independent
reviewer Professor Elizabeth Beattie (EB).

Selection of studies
The search results will be merged using reference management
software and duplicate records removed. Two review authors (LC
and JS-P) will independently screen the search results at three
levels: (1) titles, (2) abstracts to assess which studies satisfy the
inclusion criteria, and (3) full text copies of the papers that are
potentially relevant. Obviously irrelevant reports will be removed.
Multiple reports of the same study will be linked. If the paper
cannot be assessed for relevance based on title or abstract, the full
text will be obtained. When suitability of a study is unclear, after
examining the full text the corresponding author will be contacted
to request clarification or additional information, or both.
Data extraction and management
Two review authors (LC and JS-P) will extract data independently
using the Template for Intervention Description and Replication
(TIDieR) checklist (Hoffmann 2014). Any discrepancies will be
resolved by discussion. The third and fourth review authors (SL
and WYA) will be consulted in the case of persistent disagreement.
Assessment of risk of bias in included studies
Two review authors (LC and JS-P) working independently will
assess the methodological quality of the included studies using
the Cochrane ’Risk of bias’ assessment tool (Higgins 2011). We
will assess studies for random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective reporting
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and anything else that might lead to a systematic underestimate,
or overestimate, of the difference between groups. Two review authors (SL and WYA) will assess the risk of bias independently and
discrepancies will be resolved by discussion. An arbitrator will be
consulted in the case of persistent disagreement.

Measures of treatment effect
All results will be presented with 95% confidence intervals.
Dichotomous data: The effect measure for dichotomous outcomes
will be the odds ratio.
Continuous data: The effect measure for continuous data will be
the mean difference where arithmetic means and standard deviations are provided. If the same outcome is measured using different scales, then the standardised mean difference will be used.
Geometric mean ratios will be used if continuous outcomes are
summarised using geometric means. Medians and ranges will be
reported in a table.
Count data: Effect measures for counts and rates will be rate ratios.
Time-to-event data: Time-to-event data will be compared using
hazard ratios.

Dealing with missing data
Authors will be contacted and asked to supply the study protocol
and full information for any outcomes reported inadequately. In
addition, for outcomes mentioned in articles or protocols but not
reported, we will ask authors to clarify whether those outcome
measures were in fact analysed, and if so to supply the data. The
completeness of outcome data for each main outcome will be
described including attrition and exclusions from the analysis. We
will report parameters such as the numbers in each intervention
group (compared with total randomised participants), reasons for
attrition/exclusions and any re-inclusions.

Assessment of heterogeneity
We will report variability between the included studies in terms
of study design, participants, settings, interventions, comparisons,
outcome assessment and outcome measures.
Substantial statistical heterogeneity will be suggested by the following indicators: poor overlap of confidence intervals on forest
plots; high Chi2 values, P > 0.10, and I2 statistic > 50.

Assessment of reporting biases
Unit of analysis issues
We anticipate including cluster randomised trials. Where these
report analyses which account for cluster randomisation, we will
check that the method used was appropriate. If no correct analysis
accounting for the cluster randomisation is reported, then we will
attempt to re-analyse the data following the Cochrane Handbook
guidelines (Higgins 2011). Where studies report outcomes at multiple time points, we will consider meta-analysis using methods
described by Peters and Mengersen (Peters 2008), depending on
the availability of summary effects, number of repeated outcome
measures, between-subjects and within-subjects variance, difference between outcome measures at different time-points and slope
estimate for trend. Meta-analyses will be conducted in the following circumstances:
• given time point, where most studies report one given time
point and others report multiple time points;
• first/last time point, where most studies report two time
points and a small number of studies report three or more time
points; and
• all time points, where most studies report three or more
time points.
If a study does not report appropriate results, we will not re-analyse the data because no estimate of within-subjects variation can
be obtained and any re-analysis would underestimate, or overestimate, the standard error of the effect sizes. Therefore, as suggested
in the Cochrane Handbook guidelines, we will present the results
reported in the original papers only.

The possibility of selective outcome reporting will be examined
and reported.

Data synthesis
We will appraise the variability across studies (in terms of participants, interventions, comparisons and outcomes) in order to
make rational decisions about pooling data, or making particular comparisons across included studies. This assessment will include clinical heterogeneity and methodological heterogeneity. If
studies are found to be sufficiently similar to ensure a clinically
meaningful answer, we will use RevMan software to pool the results. If substantial heterogeneity is found, we will report results in
a narrative form. Where applicable, we will calculate the relative
risk and mean differences with 95% confidence intervals for categorical and continuous data, respectively. We will use a randomeffects model to take into account the (expected) heterogeneity
of the various studies. We will examine data from cluster trials
with unit of analysis errors according to the Effective Practice and
Organisation of Care (EPOC 2015) guidelines, and absolute risk
differences will be used.

Subgroup analysis and investigation of heterogeneity
Subgroup analysis, where possible, will be conducted on participant populations, in order to make comparisons between subgroups based on factors such as participant features, or subsets of
studies (e.g. study setting and its geographical location).
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Sensitivity analysis
If sufficient trials that satisfy the inclusion criteria are identified, we
will conduct sensitivity analyses regarding risk of bias to investigate
the robustness of the results in relation to the quality components.
The effect of missing data will also be investigated using sensitivity
analyses.
Presentation of results - ’Summary of findings’ table
For each outcome, we will assess the overall quality of the evidence
using the GRADE (Grades of Recommendation, Assessment, Development and Evaluation) approach. The GRADE approach defines the quality of a body of evidence as the extent to which one
can be confident that an estimate of effect or association is close

to the true quantity of specific interest (Schünemann 2011a).
We will present the main results of the review in ‘Summary of findings’ tables, which provide key information concerning the best
estimate of effect of the interventions examined, and the quantity
and the quality of the evidence behind each estimate (Schünemann
2011b). We plan to include the following main outcomes in the
’Summary of findings’ tables:
1. Frequency and severity of agitation.
2. Multi-faceted behaviours.
3. Mood.
4. Quality of life.
5. Function in activities of daily living.
6. Use of restraint, physical and/or chemical.
7. Adverse events.
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APPENDICES

Appendix 1. MEDLINE search strategy
1. exp Dementia/
2. Delirium, Dementia, Amnestic, Cognitive Disorders/
3. dement*.mp.
4. alzheimer*.mp.
5. (lewy* adj2 bod*).mp.
6. (chronic adj2 cerebrovascular).mp.
7. (“organic brain disease” or “organic brain syndrome”).mp.
8. (cerebr* adj2 deteriorat*).mp.
9. (cerebral* adj2 insufficient*).mp.
10. or/1-9
11. activity.ti,ab.
12. activities.ti,ab.
13. psychosocial.ti,ab.
14. non-pharmacological.ti,ab.
15. individually-tailor*.ti,ab.
16. personally-tailor*.ti,ab.
17. (individual or individuals or individually-cent*).ti,ab.
18. (meaning* OR meaningful*).ti,ab.
19. involvement.ti,ab.
20. (engagement or engaging).ti,ab.
21. occupational*.ti,ab.
22. personhood.ti,ab.
23. person-centred.ti,ab.
24. identity.ti,ab.
25. Personhood/ or Patient-Centred Care/
26. or/11-24
27. 10 and 26
28. randomized controlled trial.pt.
29. controlled clinical trial.pt.
30. randomly.ab.
31. groups.ab.
32. placebo.ti,ab.
33. randomi?ed.ti,ab.
34. (“double-blind*” or “single-blind*”).ti,ab.
35. (RCT or CCT).ti,ab.
36. or/28-35
37. 27 and 36
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